# EDGAR Filing Document

**Accession Number:** 0001824884
**File Stem:** 0001213900-23-018929
**Filing Date:** 2023-3
**Character Count:** 6456
**Document Hash:** dda27527d8eee4bde9dfa0f6354b990c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-018929.hdr.sgml**: 20230309

**ACCESSION NUMBER**: 0001213900-23-018929

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230307

**ITEM INFORMATION**: Unregistered Sales of Equity Securities

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20230309

**DATE AS OF CHANGE**: 20230309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Edoc Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001824884
- **STANDARD INDUSTRIAL CLASSIFICATION:** FATS & OILS [2070]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39689
- **FILM NUMBER:** 23720785

**BUSINESS ADDRESS:**
- **STREET 1:** 7612 MAIN STREET FISHERS
- **STREET 2:** SUITE 200
- **CITY:** VICTOR
- **STATE:** NY
- **ZIP:** 14564
- **BUSINESS PHONE:** 5856781198

**MAIL ADDRESS:**
- **STREET 1:** 7612 MAIN STREET FISHERS
- **STREET 2:** SUITE 200
- **CITY:** VICTOR
- **STATE:** NY
- **ZIP:** 14564

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **March 7, 2023**

**EDOC Acquisition Corp.** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-39689** | **N/A** |
| (State or other jurisdiction<br> of incorporation) | (Commission File Number) | (IRS Employer<br> Identification No.) |

---

**7612 Main Street Fishers**

**Suite 200**

**Victor, NY 14564**

(Address of principal executive offices, including zip code)

Registrant's telephone number, including area code: **(585) 678-1198**

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Ordinary Shares, $.0001 par value per share | ADOC | The Nasdaq Stock Market LLC |
| Rights, exchangeable into one-tenth of one Class A Ordinary Share | ADOCR | The Nasdaq Stock Market LLC |
| Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share | ADOCW | The Nasdaq Stock Market LLC |

---

**Item 3.02 Unregistered Sales of Equity Securities.**

On March 7, 2023, Edoc Acquisition Corp. (the "Company") issued an aggregate of 1,685,152 (the "Sponsor Shares") of the Company's Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares") to American Physicians LLC, the sponsor of the Company (the "Sponsor"), upon the conversion (the "Sponsor Conversion") of an equal number of the Company's Class B Ordinary Shares, par value $0.0001 per share ("Class B Ordinary Shares"), held by the Sponsor.

On March 7, 2023, the Company issued an aggregate of 564,847 Class A Ordinary Shares (together with the Sponsor Shares, the "Converted Class A Ordinary Shares") to Sea Otter Securities, Stichting Juridisch Eigendom Mint Tower Arbitrage Fund, Feis Equities LLC, Yakira Capital Management, Inc., Yakira Enhanced Offshore Fund and Yakira Partners LP, MAP 136 Segregated Portfolio and Meteora Capital Partners, LP (collectively, the "Backstop Investors") upon the conversion of an equal number of the Company's Class B Ordinary Shares held by the Backstop Investors (together with the Sponsor Conversion, the "Conversion").

The Converted Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions as applied to the Class B Ordinary Shares before the Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination as described in the prospectus for the Company's initial public offering. Following the Conversion, there are 3,658,377 Class A Ordinary Shares issued and outstanding and one Class B Ordinary Shares issued and outstanding. As a result of the Conversion, the Sponsor holds approximately 57.3% of the Company's Class A Ordinary Shares that are outstanding and the Backstop Investors hold approximately 1.5% of the Company's Class A Ordinary Shares that are outstanding.

The issuance of the Converted Class A Ordinary Shares upon the Conversion has not been registered under the Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(9) thereof.

**Item 7.01 Regulation FD Disclosure.**

The disclosure set forth above in Item 3.02 of this Current Report on Form 8-K is incorporated by reference in this Item 7.01.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **EDOC Acquisition Corp.** | **EDOC Acquisition Corp.** | **EDOC Acquisition Corp.** |
| Date: March 9, 2023 | By: | /s/ Kevin Chen | /s/ Kevin Chen |
|  |  | Name: | Kevin Chen |
|  |  | Title: | Chief Executive Officer |

---